Log in to save to my catalogue

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10071594

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Treatment with therapy targeting BRAF and MEK (BRAF/MEK) has revolutionized care in melanoma and other cancers; however, therapeutic resistance is common and innovative treatment strategies are needed
1
,
2
. Here we studied a group of patients with melanoma who were treated with neoadjuvant BRAF/MEK-targeted therapy (
NCT02231775

Alternative Titles

Full title

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10071594

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10071594

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-022-04833-8

How to access this item